EpiCept puts price on its shares
-
- August
- 4
EpiCept Corp. of Eastview said this morning the 5.53 million shares of its stock available in an upcoming public offering will be priced at 54.3 cents apiece. The five-year warrants to buy up to 2.76 million shares will carry an exercise price of 48 cents a share, the company said.
EpiCept will take in about 2.65 million in net proceeds from the offering. The company plans to use the money for general corporate purposes and to repay a portion of a secured loan.
The company is seeking to develop drugs for cancer patients.
EpiCept last week announced it had received a regulatory approval in Europe for Ceplene, a treatment for a type of leukemia. The Committee for Medicinal Products for Human Use issued a positive opinion regarding the marketing of Ceplene.
The company’s shares were trading at 58 cents, down 8 cents, at about 10:20 a.m.









